Laporan Kasus Stemi

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 41
At a glance
Powered by AI
The key takeaways from the document are that it discusses the case report of a 61-year-old male patient presenting with chest pain diagnosed with ST segment elevation inferior myocardial infarction. It details the patient's history, physical exam findings, diagnostic tests, treatment, and prognosis.

The symptoms of ST segment elevation inferior myocardial infarction in this case include chest pain radiating to the left arm and neck, shortness of breath, dyspnea on exertion, nausea, and cold sweat.

The diagnostic criteria for ST segment elevation myocardial infarction discussed in the document include ischemic symptoms, changes in the electrocardiogram showing ST segment elevation and T wave inversion, and elevated cardiac biomarkers such as troponin and CK-MB.

APRIL 2016

CASE REPORT:
ST SEGMENT ELEVATION
INFERIOR MYOCARDIAL INFARCTION
ONSET > 24 HOURS KILLIP II

Presented by:
Nurhafidah Mahfudz C111 12 058
Andi Saputri Majid C111 12 057
Andi Idil Saputra C111 12 059
Hartati Hamzi C111 12 062

Supervisor:
dr. Abdul Hakim, Sp.JP, FIHA
PATIENT IDENTITY

 Name : Mr. B
 Age : 61 years old
 Address : Mattoanging
 MR : 532990
 Date of Admission : 19/4/2016
HISTORY TAKING

 Chief complaint : Chest pain


 Present Illness History :
 Suffered since 1 day before admission

 Described as burned and compressed pain on the left side


and radiating to left arm and neck, intermittently, duration
of pain : 20-30 minutes, accompanied with cold sweat.
 The intensity is not influeced by activity or rest

 Shortness of breath (+)

 DOE (+)

 PND (+)

 Nausea (+), no vomitting


HISTORY TAKING

 Past Illness History :


 No history of hypertension
 No history of Diabetes Mellitus
 No history of alcohol consumption
 History of smoking (+)
 No history of previous chest pain and heart disease
 No family history with heart disease
 History of lung TB on 2015
RISK FACTOR

Modified Risk Factor


• Smoking

Non-modified risk factor:


• Gender : Male
• Age : 61 years
PHYSICAL EXAMINATION
 General Status
 Moderate illness / Under Nutrition/ Composmentis
 Weight : 45 kg
 Height : 161 cm
 BMI : 17.37 kg/m2
 Vital Status
 Blood pressure :120/70 mmHg
 Heart rate : 100 bpm
 Respiratory rate : 28 rpm
 Temperature : 36,5 oC
PHYSICAL EXAMINATION

 Head : anemic (-) icteric (-)


 Neck : JVP R+2 cmH2O,
 Lung :
 Inspection : symmetry left=right
 Palpation : mass (-), no tenderness, normal vocal
fremitus
 Percussion : sonor
 Auscultation : vesicular, ronchi +/+, wheezing +/+
PHYSICAL EXAMINATION

 Cor :
 Inspection : ictus cordis not visible
 Palpation : ictus cordis is palpable, thrill (-)
 Percussion :
 Upper border 2nd ICS sinistra

 Right border 4th ICS linea parasternalis dextra

 Left border 5th ICS linea midclavicularis sinistra

 Auscultation : heart sound I/II regular, murmur (-)


PHYSICAL EXAMINATION

 Abdomen :
 Inspection : flat, follows breath movement
 Auscultation : peristaltic (+), normal
 Palpation : liver and spleen not palpable
 Percussion : tympani

 Extremities :
 Edema (-)
ELECTROCARDIOGRAPHY

Rhythm : sinus rhytm QRS complex : Q wave in II, III, aVF


Heart Rate : 91 bpm Duration of QRS : 0.06 sec
Regularity : reguler ST segment : elevation in II, III, aVF
P wave : 0.06 sec T wave : T inverted in II, III, aVF
PR interval : 0.16 sec
Axis : extreme right axis deviation Conclusion: STEMI inferior
LABORATORY FINDINGS

TEST RESULT Normal value

RBC 4,67x106/l 4,50-6,50x106/l

WBC 19,4 x103 /l 4,0-10,0 x 103 /l

HGB 13,91 g/dl 14,0-18,0 g/dl

HCT 43,2% 40,0-54,0 %

PLT 236x 103 /l 150-400 x 103 /l


LABORATORY FINDINGS

Test Result Normal value

GDS 115 mg/dl 140 mg/dl

Ureum 41 mg/dl 10-50 mg/dl

Creatinin 1,25 mg/dl M(<1,3);F(<1,1) mg/dl

SGOT 13 U/l <38 U/l

SGPT 9 U/l <41 U/l

Natrium 135 mmol/l 136-145 mmol/l

Kalium 4,2 mmol/l 3,5-5,1 mmol/l

Klorida 103 mmol/l 97-111 mmol/l


LABORATORY FINDINGS

Test Result Normal value


CK 31 U/l L(<190)P(<167) U/l

CK-MB 13 U/l <25 U/l

Troponin I 0,05 ng/ml <0,01 ng/ml

PT 10,9 detik 10-14 detik

aPTT 33,6 detik 22-30 detik

INR 1,05 detik --


CHEST X-RAY

Conclusion:
- CTI 0,31 (normal)
- Active pulmonary TB
- Lymphadenopathy hilar dextra
ECHOCARDIOGRAPHY

• Normal left and right ventricular systolic


function
• Concentric left ventricular hypertrophy
• Diastolic dysfunction grade I
DIAGNOSIS

1. ST Elevation Extensive Inferior Myocardial


Infarction (STEMI) onset >24 hours, KILLIP II

2. CAP, DD/ Syndrom Obstruction Post TB

3. Diastolic Dysfunction
TREATMENT

 O2 2-4 L/min via nasal cannula


 IVFD NaCl 0,9% 500 cc/24 hours
 Aspilet 160 mg (loading dose), maintenance 1x80 mg tab
 Clopidogrel 300 mg(loading dose), maintenance 1x75 mg
tab
 Captopril 12,5 mg/12jam/oral
 Bisoprolol 1.25mg/24jam/oral
 Nitroglycerin 1mg/jam/ SP
 Atorvastatin 40mg/24 hours/oral
 Arixtra 2,5 mg/24 hours/subcutaneous
 Laxadine syr 0-0-2 tsp
 Alprazolam 0,5 mg 0-0-1
DISCUSSION
INTRODUCTION

Acute coronary syndromes


(ACS) is a term for situations
where the blood supplied to the
heart muscle is suddenly blocked.
• described as a group of
conditions resulting from acute
myocardial ischemia
(insufficient blood flow to heart
muscle)
• ranging from unstable angina
(increasing, unpredictable
chest pain) to myocardial
infarction (heart attack).
ACS Classification
20

Acute Coronary Syndrome


A. Unstable angina pectoris
B. NSTEMI
C. STEMI
Introduction

• Myocardial ischemia is caused by imbalance


between myocardial oxygen supply and
myocardial oxygen consumption.
• Myocardial infarction (MI) is the rapid
development of myocardial necrosis.

European Heart Journal. Guidelines on the management of stable angina pectoris


Regions of the Myocardium

Lateral
I, AVL,V5-V6

Inferior
II, III, aVF Anterior / Septal
V1-V4
Pathophysiology
RISK FACTORS

Modifiable Non-
Modifiable
CLINICAL PATHWAY
WHO DIAGNOSTIC CRITERIA

• Prolonged chest pain


Ischemic Usually retrosternal location
symptoms • Dyspnea
• Diaphoresis

Diagnostic • Inverted T wave


• ST segment depression or elevation
ECG changes • Pathological Q wave

Serum cardiac • Troponin-T atau I


• CK-MB
marker • CK
elevations • Myoglobin
ISCHEMIC SYMPTOMS
ECG CHANGES

Hyperacute Phase Complete Evolution Old Infarct


• Non specific ST- • Specific ST-Elevation • Q-Pathologic
Elevation • T inverted • ST segment isoelectric
• T taller and wider • Q-Pathologic • T normal or inverted
CARDIAC BIOMARKERS
GOAL OF TREATMENT

Relieve pain Hemodynamic


stabilization

Myocardial Prevent the


reperfusion complication
Reperfusion Therapy for Patients with STEMI

*Patients with cardiogenic shock or severe heart failure initially seen at a non–PCI-capable hospital should be transferred for cardiac
catheterization and revascularization as soon as possible, irrespective of time delay from MI onset (Class I, LOE: B). †Angiography and
revascularization should not be performed within the first 2 to 3 hours after administration of fibrinolytic therapy.
- Reperfusion Therapy -
Thrombolitik
ALTEPLASE

Alteplase 15 mg bolus iv.

50mg iv in 30minutes

35mg iv in 60minutes
TREATMENT
Bisoprolol Clinical Study shows:
-Limit area of MI
Relieve symptom -re-infarction risk decrease
NTG -prolong life span
Vasodilatation

-Plaque stabilization
-LDL decrease
target: <70mg/dl Atorvastatin -Anti-remodelling
-decrease mortality

Captopril
TREATMENT

 O2 2-4 L/min via nasal cannula


 IVFD NaCl 0,9% 500 cc/24 hours
 Aspilet 160 mg (loading dose), maintenance 1x80 mg tab
 Clopidogrel 300 mg(loading dose), maintenance 1x75 mg
tab
 Captopril 12,5 mg/12jam/oral
 Bisoprolol 1.25mg/24jam/oral
 Nitroglycerin 1mg/jam/SP
 Atorvastatin 40mg/24 hours/oral
 Arixtra 2,5 mg/24 hours/subcutaneous
 Laxadine syr 0-0-2 tsp
 Alprazolam 0,5 mg 0-0-1
ACC/AHA 2007 recommendation:
Loading: Aspirin 300mg Decrease mortality
Clopidogrel 300mg Decrease re-infarction rate

CURE study reported:


Maintanance:
Aspirin 80mg+Clopidogrel 75mg (for1year)

decrease 20% mortality risk,


infark myocardial non fatal,
stroke
COMPLICATION
PROGNOSIS
KILLIP CLASSIFICATION
CLASS DESCRIPTION MORTALITY RATE (%)

I No clinical signs of heart failure 6

Rales or crackles in the lungs, an S3,


II 17
and elevated jugular venous pressure

III Acute pulmonary edema 30 - 40

Cardiogenic shock or hypotension


IV (systolic BP < 90 mmHg), and evidence 60 – 80
of peripheral vasoconstriction
THANK YOU

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy